T
TENAYA THERAPEUTICS INC
NASDAQ: TNYA (Tenaya Therapeutics, Inc.)
Last update: 12 hours ago0.850
-0.51 (-37.50%)
| Previous Close | 1.36 |
| Open | 1.05 |
| Volume | 66,485,439 |
| Avg. Volume (3M) | 3,514,819 |
| Market Cap | 141,530,016 |
| Price / Book | 2.67 |
| 52 Weeks Range | |
| Earnings Date | 10 Nov 2025 |
| Diluted EPS (TTM) | -1.15 |
| Total Debt/Equity (MRQ) | 10.81% |
| Current Ratio (MRQ) | 6.68 |
| Operating Cash Flow (TTM) | -84.95 M |
| Levered Free Cash Flow (TTM) | -48.05 M |
| Return on Assets (TTM) | -41.71% |
| Return on Equity (TTM) | -76.21% |
Market Trend
| Short Term | Medium Term | ||
| Industry | Biotechnology (US) | Mixed | Mixed |
| Biotechnology (Global) | Mixed | Mixed | |
| Stock | Tenaya Therapeutics, Inc. | Bearish | Bearish |
AIStockmoo Score
0.1
| Analyst Consensus | 3.0 |
| Insider Activity | NA |
| Price Volatility | -2.0 |
| Technical Moving Averages | 0.0 |
| Technical Oscillators | -0.5 |
| Average | 0.13 |
|
Tenaya Therapeutics Inc is a preclinical stage biotechnology company focused on discovering, developing, and delivering curative therapies that address the underlying drivers of heart disease. It is advancing product candidates from three product platforms: gene therapy, cellular regeneration, and precision medicine. |
|
| Sector | Healthcare |
| Industry | Biotechnology |
| Investment Style | Small Value |
| % Held by Insiders | 0.72% |
| % Held by Institutions | 59.67% |
Ownership
| Name | Date | Shares Held |
|---|---|---|
| Column Group Llc | 30 Sep 2025 | 9,400,290 |
| Euclidean Capital Llc | 30 Sep 2025 | 1,015,705 |
| Schonfeld Strategic Advisors Llc | 30 Sep 2025 | 465,957 |
| Stepstone Group Lp | 30 Sep 2025 | 462,163 |
| 52 Weeks Range | ||
| Price Target Range | ||
| High | 8.00 (Chardan Capital, 841.18%) | Buy |
| Median | 5.50 (547.06%) | |
| Low | 3.00 (HC Wainwright & Co., 252.94%) | Buy |
| Average | 5.50 (547.06%) | |
| Total | 2 Buy | |
| Avg. Price @ Call | 0.850 | |
| Firm | Date | Target Price | Call | Price @ Call |
|---|---|---|---|---|
| Chardan Capital | 12 Dec 2025 | 8.00 (841.18%) | Buy | 0.850 |
| 10 Nov 2025 | 9.00 (958.82%) | Buy | 1.43 | |
| HC Wainwright & Co. | 12 Dec 2025 | 3.00 (252.94%) | Buy | 0.850 |
No data within this time range.
The support, resistance and trendline levels presented has been generated by an artificial intelligence (AI) model and should be interpreted with caution.
Portfolio
| Realized Profit | - |
| Unrealized Profit | - |
| Dividend Received 2025 | - |
| Total Profit | - |
| Avg. Return | - |
| Quantity (Buy) | - |
| Avg. Price (Buy) | - |
| Quantity (Sold) | - |
| Avg. Price (Sold) | - |